These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2071697)

  • 1. Alz-50 immunoreactivity in the hypothalamus of the normal and Alzheimer human and the rat.
    Byne W; Mattiace L; Kress Y; Davies P
    J Comp Neurol; 1991 Apr; 306(4):602-12. PubMed ID: 2071697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy.
    Tabaton M; Whitehouse PJ; Perry G; Davies P; Autilio-Gambetti L; Gambetti P
    Ann Neurol; 1988 Sep; 24(3):407-13. PubMed ID: 3067653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alz-50 antibody recognizes Alzheimer-related neuronal changes.
    Hyman BT; Van Hoesen GW; Wolozin BL; Davies P; Kromer LJ; Damasio AR
    Ann Neurol; 1988 Apr; 23(4):371-9. PubMed ID: 3382173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease.
    Brady DR; Mufson EJ
    J Comp Neurol; 1991 Mar; 305(3):489-507. PubMed ID: 2037717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution of growth-hormone-releasing factor (GRF) immunoreactivity in the central nervous system of the rat: an immunohistochemical study using antisera directed against rat hypothalamic GRF.
    Sawchenko PE; Swanson LW; Rivier J; Vale WW
    J Comp Neurol; 1985 Jul; 237(1):100-15. PubMed ID: 3930577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
    J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypothalamic lateral tuberal nucleus in Alzheimer's disease.
    Kremer B; Swaab D; Bots G; Fisser B; Ravid R; Roos R
    Ann Neurol; 1991 Mar; 29(3):279-84. PubMed ID: 1710433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's disease.
    Doebler JA; Markesbery WR; Anthony A; Davies P; Scheff SW; Rhoads RE
    Ann Neurol; 1988 Jan; 23(1):20-4. PubMed ID: 2449843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-dependent cytoskeletal changes of the human hypothalamus develop independently of Alzheimer's disease.
    Schultz C; Ghebremedhin E; Braak E; Braak H
    Exp Neurol; 1999 Nov; 160(1):186-93. PubMed ID: 10630203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
    Rasool CG; Svendsen CN; Selkoe DJ
    Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of avian pancreatic polypeptide-like immunoreactivity in the rat hypothalamus.
    Card JP; Brecha N; Moore RY
    J Comp Neurol; 1983 Jun; 217(2):123-36. PubMed ID: 6886047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate-, glutaminase-, and taurine-immunoreactive neurons develop neurofibrillary tangles in Alzheimer's disease.
    Kowall NW; Beal MF
    Ann Neurol; 1991 Feb; 29(2):162-7. PubMed ID: 1672808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
    van de Nes JA; Konermann S; Nafe R; Swaab DF
    Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of dynorphin and neurokinin B immunoreactivity in the rat hypothalamus: Morphologic evidence of interrelated function within the arcuate nucleus.
    Burke MC; Letts PA; Krajewski SJ; Rance NE
    J Comp Neurol; 2006 Oct; 498(5):712-26. PubMed ID: 16917850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of catecholamine neurons in the hypothalamus and preoptic region of mouse.
    Ruggiero DA; Baker H; Joh TH; Reis DJ
    J Comp Neurol; 1984 Mar; 223(4):556-82. PubMed ID: 6143768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the dorsomedial nucleus of the thalamus in Alzheimer's disease.
    Paskavitz JF; Lippa CF; Hamos JE; Pulaski-Salo D; Drachman DA
    J Geriatr Psychiatry Neurol; 1995 Jan; 8(1):32-7. PubMed ID: 7710644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of tyrosine-hydroxylase-immunoreactive neurons in the hypothalamus of rats.
    Chan-Palay V; Záborszky L; Köhler C; Goldstein M; Palay SL
    J Comp Neurol; 1984 Aug; 227(4):467-96. PubMed ID: 6147362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.
    Gómez-Ramos P; Mufson EJ; Morán MA
    Microsc Res Tech; 2001 Oct; 55(1):48-58. PubMed ID: 11596149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.